Novel method for the determination of solubility in aerosol propellants

Abhishek Gupta, Paul B Myrdal

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

A new on-line reverse-phase high-performance liquid chromatography method to determine the solubility of compounds in propellant-based metered-dose inhaler (MDI) formulations was developed. The new method uses a direct injection from an MDI vial into the port of a manual injector. The MDI vials were coupled with a filtration and injection assembly to filter the excess compound, and deliver the filtrate of the MDI vials to the injector port of the manual injector. A backpressure regulator was connected to the manual injector, to maintain the propellant in the liquid state after injection from the MDI vial. Phase separation studies were conducted to investigate the miscibility of hydrofluoroalkane 134a with different mobile-phase solvent compositions. Characterization of the new direct injection method was done by evaluating sample presentation and chromatography variables to determine the robust nature of the method. Beclomethasone dipropionate in ethanol/hydrofluoroalkane 134a was used as a model system for development. A chemically diverse set of nine compounds was used to evaluate solubility measurement reproducibility. Solubilities were determined at two different temperatures (25 and 37°C) and the average relative standard deviation for all of the solubility measurements was <4%.

Original languageEnglish (US)
Pages (from-to)2411-2419
Number of pages9
JournalJournal of Pharmaceutical Sciences
Volume93
Issue number10
DOIs
StatePublished - Oct 2004

Fingerprint

Aerosol Propellants
Metered Dose Inhalers
HFA 134a
Solubility
Injections
Direct injection
Propellants
Beclomethasone
High performance liquid chromatography
Reverse-Phase Chromatography
Chromatography
Phase separation
Ethanol
High Pressure Liquid Chromatography
Temperature
Liquids
Chemical analysis

Keywords

  • Aerosol
  • HFA 134a
  • HPLC (high-performance/pressure liquid chromatography)
  • Metered-dose inhaler
  • Pulmonary drug delivery
  • Solubility

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Chemistry(all)
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science

Cite this

Novel method for the determination of solubility in aerosol propellants. / Gupta, Abhishek; Myrdal, Paul B.

In: Journal of Pharmaceutical Sciences, Vol. 93, No. 10, 10.2004, p. 2411-2419.

Research output: Contribution to journalArticle

@article{c9f302c4a3c040c48dba553c22b77753,
title = "Novel method for the determination of solubility in aerosol propellants",
abstract = "A new on-line reverse-phase high-performance liquid chromatography method to determine the solubility of compounds in propellant-based metered-dose inhaler (MDI) formulations was developed. The new method uses a direct injection from an MDI vial into the port of a manual injector. The MDI vials were coupled with a filtration and injection assembly to filter the excess compound, and deliver the filtrate of the MDI vials to the injector port of the manual injector. A backpressure regulator was connected to the manual injector, to maintain the propellant in the liquid state after injection from the MDI vial. Phase separation studies were conducted to investigate the miscibility of hydrofluoroalkane 134a with different mobile-phase solvent compositions. Characterization of the new direct injection method was done by evaluating sample presentation and chromatography variables to determine the robust nature of the method. Beclomethasone dipropionate in ethanol/hydrofluoroalkane 134a was used as a model system for development. A chemically diverse set of nine compounds was used to evaluate solubility measurement reproducibility. Solubilities were determined at two different temperatures (25 and 37°C) and the average relative standard deviation for all of the solubility measurements was <4{\%}.",
keywords = "Aerosol, HFA 134a, HPLC (high-performance/pressure liquid chromatography), Metered-dose inhaler, Pulmonary drug delivery, Solubility",
author = "Abhishek Gupta and Myrdal, {Paul B}",
year = "2004",
month = "10",
doi = "10.1002/jps.20154",
language = "English (US)",
volume = "93",
pages = "2411--2419",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - Novel method for the determination of solubility in aerosol propellants

AU - Gupta, Abhishek

AU - Myrdal, Paul B

PY - 2004/10

Y1 - 2004/10

N2 - A new on-line reverse-phase high-performance liquid chromatography method to determine the solubility of compounds in propellant-based metered-dose inhaler (MDI) formulations was developed. The new method uses a direct injection from an MDI vial into the port of a manual injector. The MDI vials were coupled with a filtration and injection assembly to filter the excess compound, and deliver the filtrate of the MDI vials to the injector port of the manual injector. A backpressure regulator was connected to the manual injector, to maintain the propellant in the liquid state after injection from the MDI vial. Phase separation studies were conducted to investigate the miscibility of hydrofluoroalkane 134a with different mobile-phase solvent compositions. Characterization of the new direct injection method was done by evaluating sample presentation and chromatography variables to determine the robust nature of the method. Beclomethasone dipropionate in ethanol/hydrofluoroalkane 134a was used as a model system for development. A chemically diverse set of nine compounds was used to evaluate solubility measurement reproducibility. Solubilities were determined at two different temperatures (25 and 37°C) and the average relative standard deviation for all of the solubility measurements was <4%.

AB - A new on-line reverse-phase high-performance liquid chromatography method to determine the solubility of compounds in propellant-based metered-dose inhaler (MDI) formulations was developed. The new method uses a direct injection from an MDI vial into the port of a manual injector. The MDI vials were coupled with a filtration and injection assembly to filter the excess compound, and deliver the filtrate of the MDI vials to the injector port of the manual injector. A backpressure regulator was connected to the manual injector, to maintain the propellant in the liquid state after injection from the MDI vial. Phase separation studies were conducted to investigate the miscibility of hydrofluoroalkane 134a with different mobile-phase solvent compositions. Characterization of the new direct injection method was done by evaluating sample presentation and chromatography variables to determine the robust nature of the method. Beclomethasone dipropionate in ethanol/hydrofluoroalkane 134a was used as a model system for development. A chemically diverse set of nine compounds was used to evaluate solubility measurement reproducibility. Solubilities were determined at two different temperatures (25 and 37°C) and the average relative standard deviation for all of the solubility measurements was <4%.

KW - Aerosol

KW - HFA 134a

KW - HPLC (high-performance/pressure liquid chromatography)

KW - Metered-dose inhaler

KW - Pulmonary drug delivery

KW - Solubility

UR - http://www.scopus.com/inward/record.url?scp=4844222139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4844222139&partnerID=8YFLogxK

U2 - 10.1002/jps.20154

DO - 10.1002/jps.20154

M3 - Article

C2 - 15349951

AN - SCOPUS:4844222139

VL - 93

SP - 2411

EP - 2419

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 10

ER -